Assertio, Garda Therapeutics amend merger as Garda raises all-cash offer to acquire all outstanding Assertio shares for $21.80 per share with no CVR
https://finviz.com/quote?t=ASRT&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.